References
Original article
Roofeh, D. et al. Tocilizumab prevents progression of early systemic sclerosis associated interstitial lung disease. Arthritis Rheumatol. https://doi.org/10.1002/art.41668 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McHugh, J. Tocilizumab prevents ILD progression in early SSc. Nat Rev Rheumatol 17, 188 (2021). https://doi.org/10.1038/s41584-021-00597-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-021-00597-z
- Springer Nature Limited